35 participants
Combining Neo-adjuvant ATR-inhibition With Nodal SBRT for Early-stage Resectable HPV+ OPSCCs
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-08
- Start Date:
- 2026-08-31
- Completion:
- 2030-05-31
Conditions
- HPV Positive Oropharyngeal Squamous Cell Carcinoma
- Squamous Cell Carcinoma
- HPV (Human Papillomavirus)-Associated Carcinoma
- HPV Associated Cancers
- Oropharyngeal HPV Squamous Cell Carcinoma
Interventions
- DRUG
- RADIATION
No Results Yet